Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laura Trevisani"'
Autor:
Andrea Rossi, Corinna Bergamini, Flavio Ribichini, Francesca La Russa, Laura Trevisani, Flavia Torelli, Luca Ghiselli, Annamaria Molino, Giulia Vinco, Giorgio Golia, Giulia Dolci, Giovanni Benfari, Stella Truong
Publikováno v:
Clinical Cardiology. 41:349-353
BACKGROUND: Trastuzumab (TZ) therapy requires careful monitoring of left ventricular (LV) ejection fraction (LVEF) because it can be potentially cardiotoxic. However, LVEF is an imperfect parameter and there is a need to find other variables to predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0118c7e0566d709bdb97ca4ff30e15
https://doi.org/10.1002/clc.22872
https://doi.org/10.1002/clc.22872
Autor:
Mariapina Gallo, Georgios Eleftheriou, Laura Trevisani, Mauro Gori, Filippo Taddei, Roberto Fiocchi
Publikováno v:
International journal of clinical pharmacology and therapeutics. 57(5)
Vemurafenib and cobimetinib are extremely effective in treating V600E-mutated metastatic melanoma, but their use is associated with toxic cardiac effects. Vemurafenib-induced prolonged QTc interval may be associated with ventricular fibrillation and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec82791d39bdc38dae12503e9316578
https://pubmed.ncbi.nlm.nih.gov/30704555
https://pubmed.ncbi.nlm.nih.gov/30704555
Autor:
Corinna Bergamini, Giorgio Golia, Stella Truong, Giulia Dolci, Francesca La Russa, Flavia Torelli, Luca Ghiselli, Laura Trevisani, Giulia Vinco, Annamaria Molino, Flavio Ribichini, Giovanni Benfari, Andrea Rossi
Publikováno v:
The American journal of cardiology. 122(5)
Trastuzumab is a key therapy for patients with human epidermal growth factor receptor 2 positive breast cancer (BC). However, it may cause left ventricular dysfunction, resulting in withdrawal of therapy. Left atrium (LA) enlargement has proven to cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::644d26d8d31ce646586f714dcfd3fb39
https://pubmed.ncbi.nlm.nih.gov/30053998
https://pubmed.ncbi.nlm.nih.gov/30053998
Autor:
Stella Truong, Annamaria Molino, Corinna Bergamini, Corrado Vassanelli, Giulia Vinco, Giulia Dolci, Giovanni Benfari, A Rossi, F. La Russa, Luca Ghiselli, Laura Trevisani, Flavia Torelli
Publikováno v:
European Heart Journal. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14b704d9adc761e758c2f7bf6c1d96f6
https://doi.org/10.1093/eurheartj/ehx501.p569
https://doi.org/10.1093/eurheartj/ehx501.p569
Autor:
Corrado Vassanelli, Giulia Vinco, Francesca La Russa, Corinna Bergamini, Flavia Torelli, Stella Truong, Laura Trevisani, Andrea Rossi, Giovanni Benfari, Giorgio Golia, Luca Ghiselli, Annamaria Molino
Publikováno v:
Minerva Cardiology and Angiology. 65
Background Adjuvant trastuzumab therapy increases survival rates in patients with early HER2-positive breast cancer, although it can be potentially cardiotoxic. The aim of this study was to evaluate the prevalence of left ventricular (LV) systolic dy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e9668578f5683f6861f8c94833f407
https://doi.org/10.23736/s0026-4725.16.04278-x
https://doi.org/10.23736/s0026-4725.16.04278-x